Limited Edition Ploom X Advanced Stripe Blue by Kosuke Kawamura

Mar.04
Limited Edition Ploom X Advanced Stripe Blue by Kosuke Kawamura
Japanese Tobacco (JT) collaborates with designer Kosuke Kawamura to launch limited edition Ploom X Advanced Stripe Blue tobacco device.

Key points:

Limited Edition Ploom X Advanced Stripe Blue by Kosuke Kawamura
Kosuke Kawamura | Image Source: hypebeast


Japan Tobacco collaborates with creative designer Kosuke Kawamura to launch a limited edition heated tobacco device, the "Ploom X Advanced Stripe Blue.


The device features a "paper tearing art" design, and limited edition accessories are also being released.


On March 3, Japan Tobacco (JT) announced on its official website that it would release a limited edition version of the "Ploom X Advanced" heated tobacco device designed by creative designer Kosuke Kawamura starting on March 4. The new product, called "SPECIAL EDITION STRIPE BLUE BY KOSUKE KAWAMURA," is priced at 980 yen (about $7) and can be purchased by consumers at the CLUB JT online store, national Ploom physical stores, and convenience stores.


According to Kohei Kawamura, the new product utilizes its signature "torn paper art" design, aiming to provide consumers with a pleasant visual and tactile experience, blending the device with artwork.


To coincide with the release of this limited edition device, JT also collaborated with Yasusuke Kawamura to launch a promotion for limited edition accessories. The promotion is taking place at Ploom X CLUB and various Ploom Shops, where consumers can purchase special edition front panels such as "Aqua Bouquet", "Rose Bouquet", "Olive Bouquet", as well as limited edition accessories like the "Stripe Blue" cigarette holder tray.


It is reported that Koji Kamimura is a Japanese artist known for his unique collage paintings and paper mache crafts. He has served as the Creative Director for the UNIQLO T-shirt brand "UT" and collaborated with brands and creators in various fields such as Adidas, Seiko, and ARC'TERYX.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Altria’s Nicotine Pouch Rollout in the U.S.: On! PLUS May Launch on October 14, Not Yet FDA-Approved
Altria’s Nicotine Pouch Rollout in the U.S.: On! PLUS May Launch on October 14, Not Yet FDA-Approved
Altria’s new nicotine pouch On! PLUS™ is slated to launch in the U.S. on October 14, debuting in North Carolina, Texas, and Florida. The product uses NICOSILK™ technology and will offer multiple nicotine strengths. FDA approval has not yet been granted, but Helix says it is proceeding in line with compliance requirements.
Oct.11 by 2FIRSTS.ai
Tyumen Regional Parliament in Russia Reviewing Bill to Impose Total Ban on E-Cigarette Sales
Tyumen Regional Parliament in Russia Reviewing Bill to Impose Total Ban on E-Cigarette Sales
Russia's Tyumen Council is considering a bill to ban e-cigarettes and vaping products, sparking concerns about potential risks.
Oct.13 by 2FIRSTS.ai
Russian Lawmakers Propose Criminalizing E-Cigarette Manufacture and Distribution, Citing Health Risks
Russian Lawmakers Propose Criminalizing E-Cigarette Manufacture and Distribution, Citing Health Risks
Russian lawmakers propose criminalizing e-cigarette manufacturing, storage, sales, and use, citing drug crime model for penalties.
Oct.14 by 2FIRSTS.ai
DARE Warns Malaysia: Vaping Bans Will Expand Illicit Market; Strengthen Enforcement Within Existing Framework
DARE Warns Malaysia: Vaping Bans Will Expand Illicit Market; Strengthen Enforcement Within Existing Framework
Malaysia’s policy think tank Datametrics Research and Information Sdn Bhd (DARE) cautions that state- or nationwide bans on e-cigarettes would fuel the illicit market, weaken investor confidence, reduce tax revenues, and cost jobs. DARE argues that authorities should prioritize consistent enforcement under existing laws rather than impose new prohibitions.
Sep.28 by 2FIRSTS.ai
Inter Tabac 2025: 2Firsts Provides Exclusive Coverage of New Tobacco Products and Industry Trends
Inter Tabac 2025: 2Firsts Provides Exclusive Coverage of New Tobacco Products and Industry Trends
2Firsts provides exclusive coverage of Inter Tabac 2025, capturing new tobacco products and industry trends for readers.
Sep.18 by 2FIRSTS.ai
Special Report | EU Cardiovascular Health Plan Consultation Sparks Debate on Regulation of Novel Tobacco Products, Potentially Shaping TPD III
Special Report | EU Cardiovascular Health Plan Consultation Sparks Debate on Regulation of Novel Tobacco Products, Potentially Shaping TPD III
The EU’s consultation on the Cardiovascular Health Plan, though not mentioning nicotine, has sparked debate over novel tobacco regulation. Advocates urge evidence-based recognition of harm reduction products, while opponents call for tighter rules. The plan may influence TPD III, drawing close scrutiny from both industry and health groups.
Sep.01